A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination
We report a patient, with history of vitiligo vulgaris and 8 years of type 2 diabetes, who came to our institution because of fever, weight loss, asthenia and thyrotoxicosis occurred 4 weeks later the administration of BNT162B2 (Pfizer-BioNTech) SARS-CoV-2 vaccine. Clinical, biochemical and instrumental work-up demonstrated Graves' disease and autoimmune diabetes mellitus. The occurrence of these disorders could be explained through different mechanism such as autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome), mRNA "self-adjuvant" effect, molecular mimicry between human and viral proteins and immune disruption from external stimuli. However further studies are needed to better understand the underlying pathogenesis of AIED following SARS-CoV-2 vaccine.PMID:34653776 | PMC:PMC8506108 | DOI:10.1016/j.jaut.2021.102738
Source: Journal of Autoimmunity - Category: Allergy & Immunology Authors: Armando Patrizio Silvia Martina Ferrari Alessandro Antonelli Poupak Fallahi Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Environmental Health | Genetics | Pfizer | Respiratory Medicine | SARS | Study | Vaccines | Vitiligo | Weight Loss